Here’s what you should know.
1. Tenet’s earnings per share have rapidly decreased over the past five years, to the tune of 43.70 percent.
2. Yet, analysts believe Tenet’s recent growth is positioning it for future growth.
3. Year-to-date, Tenet’s value has increased 52.97 percent.
4. A majority of market analysts currently view Tenet as a “buy.”
More articles on transactions/valuations:
5 things to know about Eastwind Surgical
Make sure your ASC’s revenue cycle management consultant has these 4 qualifications
Montecito Medical makes another splash, acquires 2 Resurgens Orthopaedics properties — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
